Platelet-activating factor in brain regions after transient ischemia in gerbils

Stroke

Volumn 27, Issue 3, 1996, Pages 514-519

  Nishida, Keiji ^a   Markey, S P ^a  

^a NATIONAL INSTITUTE OF MENTAL HEALTH   (United States)

Author keywords

gerbils; platelet activating factor; spectrum analysis, mass

Indexed keywords

THROMBOCYTE ACTIVATING FACTOR;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BIOASSAY; BRAIN REGION; CONTROLLED STUDY; GAS CHROMATOGRAPHY; GERBIL; MASS SPECTROMETRY; MEDIATOR; NEUROPATHOLOGY; NONHUMAN; PRIORITY JOURNAL; THROMBOCYTE ACTIVATION; TRANSIENT ISCHEMIC ATTACK;

EID: 0029947307     PISSN: 00392499     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.STR.27.3.514     Document Type: Article

References (35)

1. Braquet P, Touqui L, Shen TY, Vargaftig BB. Perspectives in platelet-activating factor research. Pharmacol Rev. 1987;39:97-145.
2. Frerichs KU, Feuerstein GZ. Platelet-activating factor: key mediator in neuroinjury? Cerebrovasc Brain Metab Rev. 1990;2: 148-160.
3. Yue TL, Feuerstein GZ. Platelet-activating factor: a putative neuromodulator and mediator in the pathophysiology of brain injury. Crit Rev Neurobiol. 1994;8:11-24.
4. Panetta T, Marcheselli VL, Braquet P, Spinnewyn B, Bazan NG. Effects of a platelet activating factor antagonist (BN 52021) on free fatty acids, diacylglycerols, polyphosphoinositides and blood flow in the gerbil brain: inhibition of ischemia-reperfusion induced cerebral injury. Biochem Biophys Res Commun. 1987;149:580-587.
5. Clay KL, Johnson C, Worthen GS. Biosynthesis of platelet activating factor and 1-O-acyl analogues by endothelial cells. Biochim Biophys Acta. 1991;1094:43-50.
6. Clay KL. Quantitation of platelet-activating factor by gas chromatography-mass spectrometry. Methods Enzymol. 1990;187:134-142.
7. Lindsberg PJ, Hallenbeck JM, Feuerstein G. Platelet-activating factor in stroke and brain injury. Ann Neurol. 1991;30:117-129.
8. Satouchi K, Pinckard RN, Hanahan DJ. Influence of alkyl ether chain length of acetyl glyceryl ether phosphorylcholine and its ethanolamine analog on biological activity toward rabbit platelets. Arch Biochem Biophys. 1981;211:683-688.
9. Nowak TSJ. Localization of 70 kDa stress protein mRNA induction in gerbil brain after ischemia. J Cereb Blood Flow Metab. 1991;11: 432-439.
10. Spinnewyn B, Blavet N, Clostre F, Bazan N, Braquet P. Involvement of platelet-activating factor (PAF) in cerebral postischemic phase in Mongolian gerbils. Prostaglandins. 1987;34: 337-349.
11. Prehn JH, Krieglstein J. Platelet-activating factor antagonists reduce excitotoxic damage in cultured neurons from embryonic chick telencephalon and protect the rat hippocampus and neocortex from ischemic injury in vivo. J Neurosci Res. 1993;34:179-188.
12. Oberpichler H, Sauer D, Rossberg C, Mennel HD, Krieglstein J. PAF antagonist ginkgolide B reduces postischemic neuronal damage in rat brain hippocampus. J Cereb Blood Flow Metab. 1990; 10:133-135.
13. Kornecki E, Ehrlich HY. Neuroregulatory and neuropathological actions of the ether-phospholipid platelet-activating factor. Science. 1988;240:1792-1794.
14. Smith ML, Auer RN. Siesjö BK. The density and distribution of ischemic brain injury in the rat following 2-10 min of forebrain ischemia. Acta Neuropathol (Berl). 1984;64:319-332.
15. Bonavida B, Mencia-Huerta JM, Braquet P. Effect of platelet-activating factor on monocyte activation and production of tumor necrosis factor. Int Arch Allergy Appl Immunol. 1989;88:157-160.
16. Dubois C, Bissonnette E, Rola-Pleszczynski M. Platelet-activating factor (PAF) enhances tumor necrosis factor production by alveolar macrophages: prevention by PAF receptor antagonists and lipoxygenase inhibitors. J Immunol. 1989;143:964-970.
17. Robinson M, Blank ML, Snyder F. Acylation of lysophospholipids by rabbit alveolar macrophages: specificities of CoA-dependent and CoA-independent reactions. J Biol Chem. 1985;260:7889-7895.
18. Chilton FH, O'Flaherty JT, Ellis JM, Swendsen CL, Wykle RL. Selective acylation of lyso platelet activating factor by arachidonate in human neutrophils. J Biol Chem. 1983;258:7268-7271.
19. Ramesha CS, Pickett WC. Platelet-activating factor and leukotriene biosynthesis is inhibited in polymorphonuclear leukocytes depleted of arachidonic acid. J Biol Chem. 1986;261:7592-7595.
20. Aveldano MI, Bazan NG. Rapid production of diacylglycerols enriched in arachidonate and stearate during early brain ischemia. J Neurochem. 1975;25:919-920.
21. Tang W, Sun GY. Metabolic relationship between arachidonate activation and its transfer to lysophospholipids by brain microsomes. Neurochem Res. 1985;10:1343-1353.
22. Gaudet RJ, Alam I, Levine L. Accumulation of cyclooxygenase products of arachidonic acid metabolism in gerbil brain during reperfusion after bilateral common carotid artery occlusion. J Neurochem. 1980;35:653-658.
23. Chilton FH, Ellis JM, Olson SC, Wykle RL. 1-O-alkyl-2-arachidonoyl-sn-glycero-3-phosphocholine: a common source of platelet-activating factor and arachidonate in human polymorphonuclear leukocytes. J Biol Chem. 1984;259:12014-12019.
24. Siesjö BK. Cell damage in the brain: a speculative synthesis. J Cereb Blood Flow Metab. 1981;1:155-185.
25. Schanne FA, Kane AB, Young EE, Farber JL. Calcium dependence of toxic cell death: a final common pathway. Science. 1979;206:700-702.
26. Silver IA, Erecinska M. Ion homeostasis in rat brain in vivo: intra-and extracellular [Ca2+] and [H+] in the hippocampus during recovery from short-term, transient ischemia. J Cereb Blood Flow Metab. 1992;12:759-772.
27. Greenberg JH, Uematsu D, Araki N, Hickey WF, Reivich M. Cytosolic free calcium during focal cerebral ischemia and the effects of nimodipine on calcium and histologic damage. Stroke. 1990; 21(suppl IV):IV-72-IV-77.
28. Bosh VD. Intracellular phospholipase A. Biochim Biophys Acta. 1980;604:191-246.
29. Francescangeli E, Goracci G. The de novo biosynthesis of platelet-activating factor in rat brain. Biochem Biophys Res Commun. 1989; 161:107-112.
30. Snyder F. Biochemistry of platelet-activating factor: a unique class of biologically active phospholipids. Proc Soc Exp Biol Med. 1989; 190:125-135.
31. Clark PO, Hanahan DJ, Pinckard RN. Physical and chemical properties of platelet-activating factor obtained from human neutrophils and monocytes and rabbit neutrophils and basophils. Biochim Biophys Acta. 1980;628:69-75.
32. Albert DH, Snyder F. Biosynthesis of 1-alkyl-2-acetyl-sn-glycero-3-phosphocholine (platelet-activating factor) from 1-alkyl-2-acyl-snglycero-3-phosphocholine by rat alveolar macrophages: phospholipase A2 and acetyltransferase activities during phagocytosis and ionophore stimulation. J Biol Chem. 1983;258:97-102.
33. Yue TL, Lysko PG, Feuerstein G. Production of platelet-activating factor from rat cerebellar granule cells in culture. J Neurochem. 1990;54:1809-1811.
34. du Bois M, Bowman PD, Goldstein GW. Cell proliferation after ischemic injury in gerbil brain: an immunocytochemical and autoradiographic study. Cell Tissue Res. 1985;242:17-23.
35. Morioka T, Kalehua AN, Streit WJ. The microglial reaction in the rat dorsal hippocampus following transient forebrain ischemia. J Cereb Blood Flow Metab. 1991;11:966-973.